Mps Pharmaa Ltd vs Panacea Biotec Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of MPS Pharmaa Ltd is ₹ 1.73 as of 27 Apr 15:30 . The P/E Ratio of MPS Pharmaa Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of MPS Pharmaa Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Panacea Biotec Ltd changed from ₹ 1086 crore on March 2021 to ₹ 2699 crore on March 2025 . This represents a CAGR of 19.96% over 5 years The revenue of MPS Pharmaa Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Panacea Biotec Ltd for the Dec '25 is ₹ 170.24 crore as compare to the Sep '25 revenue of ₹ 150.23 crore. This represent the growth of 13.32% The ebitda of MPS Pharmaa Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Panacea Biotec Ltd for the Dec '25 is ₹ 16.79 crore as compare to the Sep '25 ebitda of ₹ -8.69 crore. This represent the decline of -293% The net profit of MPS Pharmaa Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Panacea Biotec Ltd changed from ₹ -15.88 crore to ₹ 3.89 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of MPS Pharmaa Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About MPS Pharmaa Ltd

MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994.
The Company was promoted in by the Jains along with a group of dedicated professionals.
Presently, it is engaged in the manufacture and sale of pharmaceutical products in India.
It offers ethical, generic, and over the counter drugs in various formulations.
The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. The company commenced commercial production in 1997.

About Panacea Biotec Ltd

India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Limited.
The name of the Company was changed to the present 'Panacea Biotec Limited' in 1993. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines. The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively.

FAQs for the comparison of MPS Pharmaa Ltd and Panacea Biotec Ltd

Which company has a larger market capitalization, MPS Pharmaa Ltd or Panacea Biotec Ltd?

Market cap of MPS Pharmaa Ltd is 3 Cr while Market cap of Panacea Biotec Ltd is 2,214 Cr

What are the key factors driving the stock performance of MPS Pharmaa Ltd and Panacea Biotec Ltd?

The stock performance of MPS Pharmaa Ltd and Panacea Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for MPS Pharmaa Ltd and Panacea Biotec Ltd?

As of May 3, 2026, the MPS Pharmaa Ltd stock price is INR ₹1.73. On the other hand, Panacea Biotec Ltd stock price is INR ₹361.5.

How do dividend payouts of MPS Pharmaa Ltd and Panacea Biotec Ltd compare?

To compare the dividend payouts of MPS Pharmaa Ltd and Panacea Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.